Upgrade to SI Premium - Free Trial

Celestica (CLS) PT Lowered to $430 at Barclays

July 29, 2026 5:19 AM
Barclays analyst George Wang lowered the price target on Celestica (NYSE: CLS) to $430.00 (from $441.00) while maintaining a Overweight rating.

Categories

Analyst PT Change